查詢結果分析
相關文獻
- 全球健康護理基金績效研究
- 風險值及RAROC於基金績效評估之運用
- Application of VaR Bootstrapping with Fat-Tail Corrections to the Asian Emerging Equity Markets
- 原油價格風險值的估計-拔靴法的應用
- 油價對能源基金的影響
- A Bootstrap Method with Importance Resampling to Evaluate Value-at-Risk
- 風險值衡量模式之探討--以臺灣上市公司權益證券為例
- 人壽保險公司壽險契約商品組合之風險值管理研究
- 風險值體系運用之探討
- 銀行市場風險管理與市場風險值估測
頁籤選單縮合
題 名 | 全球健康護理基金績效研究=Study on Performance of Global Health Care Funds |
---|---|
作 者 | 張佳雯; 彭開琼; 葉紅櫻; | 書刊名 | 長庚科技學刊 |
卷 期 | 25 2016.12[民105.12] |
頁 次 | 頁73-84 |
分類號 | 563.538 |
關鍵詞 | 健康護理基金; 基金績效; 風險值; 拔靴法; Health care fund; Fund performance; VaR; Bootstrapping; |
語 文 | 中文(Chinese) |
中文摘要 | 本文探討重點在於以健康護理基金為研究對象,以2009 年1 月1 日至2014 年12 月31 日共六年之基金淨值為探討範圍,透過報酬率、夏普指數、b 係數、風險值等基金指標的評估,再以拔靴法挑選出最適風險值模型,最後以夏普指數與風險值的四象限分析圖,找出最佳的投資選擇,提供給投資人未來決策之參考。研究結果顯示,在平均報酬率、夏普指數與b 係數方面,駿利環球生命科技基金A 的表現皆較好,因此相對於市場的波動風險程度則較高,景順全球康健基金表現較差,但是相對於市場的波動風險程度較低。根據拔靴法選取最適風險值模型,顯示九檔健康護理基金最適風險值模型皆為相對95% VaR。而四象限圖分析的結果顯示,最佳的投資標的為新加坡大華全球保健基金與百達非專利醫藥R 兩檔健康護理基金。 |
英文摘要 | This research are focused on nine Health Care funds from 2009/1/1 to 2014/12/31 by method of rate of return, Sharpe ratio, β coefficient, VaR (value at risk) and investigated investment performance and value of risk by bootstrapping. Finally, used to Sharpe ratio and VaR made four quadrant to find out best choice of investments, offer investor suggestion of investment. The results show that Janus Global Life Sciences A has good performance by rate of return, Sharpe ratio and β coefficient but relatively high volatility risk of market; Invesco Global Health Sciences has bad performance but relatively low volatility risk of market. According to bootstrapping results that nine Health Care funds' optimum VaR model were relatively 95% VaR. Finally, nine Health Care funds made four quadrant analyses, excellent targets of investment were United Global Healthcare and Pictet-Health R. |
本系統中英文摘要資訊取自各篇刊載內容。